Year |
Citation |
Score |
2009 |
Volz TJ, Farnsworth SJ, Hanson GR, Fleckenstein AE. Measurement of plasmalemmal dopamine transport, vesicular dopamine transport, and K(+)-stimulated dopamine release in frozen rat brain tissue. Journal of Neuroscience Methods. 180: 317-20. PMID 19464519 DOI: 10.1016/J.Jneumeth.2009.03.015 |
0.595 |
|
2009 |
Farnsworth SJ, Volz TJ, Hanson GR, Fleckenstein AE. Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activation. The Journal of Pharmacology and Experimental Therapeutics. 328: 807-12. PMID 19038779 DOI: 10.1124/Jpet.108.146159 |
0.624 |
|
2009 |
Volz TJ, Farnsworth SJ, Rowley SD, Hanson GR, Fleckenstein AE. Age-dependent differences in dopamine transporter and vesicular monoamine transporter-2 function and their implications for methamphetamine neurotoxicity. Synapse (New York, N.Y.). 63: 147-51. PMID 19021208 DOI: 10.1002/Syn.20580 |
0.602 |
|
2009 |
Volz TJ, Farnsworth SJ, Hanson GR, Fleckenstein AE. Method development and validation of an in vitro model of the effects of methylphenidate on membrane-associated synaptic vesicles. Journal of Neuroscience Methods. 177: 177-82. PMID 18992277 DOI: 10.1016/J.Jneumeth.2008.10.004 |
0.484 |
|
2009 |
Fleckenstein AE, Volz TJ, Hanson GR. Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications. Neuropharmacology. 56: 133-8. PMID 18662707 DOI: 10.1016/J.Neuropharm.2008.07.002 |
0.538 |
|
2008 |
Volz TJ, Farnsworth SJ, Hanson GR, Fleckenstein AE. Methylphenidate-induced alterations in synaptic vesicle trafficking and activity. Annals of the New York Academy of Sciences. 1139: 285-90. PMID 18991873 DOI: 10.1196/Annals.1432.012 |
0.502 |
|
2008 |
Volz TJ, Farnsworth SJ, Rowley SD, Hanson GR, Fleckenstein AE. Methylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and dopamine D2 receptors. The Journal of Pharmacology and Experimental Therapeutics. 327: 161-7. PMID 18591219 DOI: 10.1124/Jpet.108.139386 |
0.486 |
|
2007 |
Volz TJ, Farnsworth SJ, King JL, Riddle EL, Hanson GR, Fleckenstein AE. Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles. The Journal of Pharmacology and Experimental Therapeutics. 323: 738-45. PMID 17693585 DOI: 10.1124/Jpet.107.126888 |
0.518 |
|
2007 |
Volz TJ, Fleckenstein AE, Hanson GR. Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment. Addiction (Abingdon, England). 102: 44-8. PMID 17493052 DOI: 10.1111/J.1360-0443.2007.01771.X |
0.621 |
|
2007 |
Bjorklund NL, Volz TJ, Schenk JO. Differential effects of Zn2+ on the kinetics and cocaine inhibition of dopamine transport by the human and rat dopamine transporters. European Journal of Pharmacology. 565: 17-25. PMID 17408612 DOI: 10.1016/J.Ejphar.2007.02.027 |
0.679 |
|
2007 |
Volz TJ, Hanson GR, Fleckenstein AE. The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficits. Journal of Neurochemistry. 101: 883-8. PMID 17250674 DOI: 10.1111/J.1471-4159.2006.04419.X |
0.64 |
|
2007 |
Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR. New insights into the mechanism of action of amphetamines. Annual Review of Pharmacology and Toxicology. 47: 681-98. PMID 17209801 DOI: 10.1146/Annurev.Pharmtox.47.120505.105140 |
0.577 |
|
2006 |
Volz TJ, Hanson GR, Fleckenstein AE. Kinetic analysis of developmental changes in vesicular monoamine transporter-2 function. Synapse (New York, N.Y.). 60: 474-7. PMID 16897727 DOI: 10.1002/Syn.20321 |
0.51 |
|
2006 |
Rau KS, Birdsall E, Volz TJ, Riordan JA, Baucum AJ, Adair BP, Bitter R, Gibb JW, Hanson GR, Fleckenstein AE. Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptake. The Journal of Pharmacology and Experimental Therapeutics. 318: 676-82. PMID 16687477 DOI: 10.1124/Jpet.105.099200 |
0.559 |
|
2006 |
Volz TJ, Hanson GR, Fleckenstein AE. Measurement of kinetically resolved vesicular dopamine uptake and efflux using rotating disk electrode voltammetry. Journal of Neuroscience Methods. 155: 109-15. PMID 16480775 DOI: 10.1016/J.Jneumeth.2006.01.002 |
0.525 |
|
2005 |
Volz TJ, Schenk JO. A comprehensive atlas of the topography of functional groups of the dopamine transporter. Synapse (New York, N.Y.). 58: 72-94. PMID 16088952 DOI: 10.1002/Syn.20183 |
0.737 |
|
2005 |
Volz TJ, Bjorklund NL, Schenk JO. Methylphenidate analogs with behavioral differences interact differently with arginine residues on the dopamine transporter in rat striatum. Synapse (New York, N.Y.). 57: 175-8. PMID 15945061 DOI: 10.1002/Syn.20161 |
0.64 |
|
2005 |
Robinson DL, Volz TJ, Schenk JO, Wightman RM. Acute ethanol decreases dopamine transporter velocity in rat striatum: in vivo and in vitro electrochemical measurements. Alcoholism, Clinical and Experimental Research. 29: 746-55. PMID 15897718 DOI: 10.1097/01.Alc.0000164362.21484.14 |
0.71 |
|
2004 |
Volz TJ, Schenk JO. L-arginine increases dopamine transporter activity in rat striatum via a nitric oxide synthase-dependent mechanism. Synapse (New York, N.Y.). 54: 173-82. PMID 15452864 DOI: 10.1002/Syn.20075 |
0.712 |
|
2004 |
Volz TJ, Kim M, Schenk JO. Covalent and noncovalent chemical modifications of arginine residues decrease dopamine transporter activity. Synapse (New York, N.Y.). 52: 272-82. PMID 15103693 DOI: 10.1002/Syn.20021 |
0.769 |
|
Show low-probability matches. |